$AGIO stock has now risen 13% today, according to our price data from Polygon. There has been approximately $24,943,146 of trading volume.
It has been the 118th most-searched ticker on Quiver Quantitative over the last day, out of 10,309 total tickers searched.
Here is what we see in our data on $AGIO (you can track the company live on Quiver's $AGIO stock page):
$AGIO Insider Trading Activity
$AGIO insiders have traded $AGIO stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by insiders over the last 6 months:
- SARAH GHEUENS (Chief Medical Officer) has made 0 purchases and 6 sales selling 21,961 shares for an estimated $853,612.
- BRIAN GOFF (Chief Executive Officer) sold 11,085 shares for an estimated $406,486
- THEODORE JAMES JR. WASHBURN (Principal Accounting Officer) sold 8,546 shares for an estimated $315,091
- CECILIA JONES (Chief Financial Officer) sold 3,651 shares for an estimated $134,247
- DAVID SCADDEN has made 0 purchases and 4 sales selling 2,000 shares for an estimated $80,968.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AGIO Hedge Fund Activity
We have seen 109 institutional investors add shares of $AGIO stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 2,049,287 shares (+485.5%) to their portfolio in Q3 2025, for an estimated $82,258,380
- PARADIGM BIOCAPITAL ADVISORS LP added 1,531,044 shares (+134.0%) to their portfolio in Q3 2025, for an estimated $61,456,106
- POLAR CAPITAL HOLDINGS PLC removed 1,002,036 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $33,327,717
- JPMORGAN CHASE & CO removed 844,317 shares (-82.2%) from their portfolio in Q3 2025, for an estimated $33,890,884
- TCG CROSSOVER MANAGEMENT, LLC added 733,038 shares (+105.2%) to their portfolio in Q3 2025, for an estimated $29,424,145
- PRICE T ROWE ASSOCIATES INC /MD/ removed 617,311 shares (-27.1%) from their portfolio in Q3 2025, for an estimated $24,778,863
- CITADEL ADVISORS LLC removed 589,488 shares (-54.5%) from their portfolio in Q3 2025, for an estimated $23,662,048
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AGIO Revenue
$AGIO had revenues of $12.9M in Q3 2025. This is an increase of 43.69% from the same period in the prior year.
You can track AGIO financials on Quiver Quantitative's AGIO stock page.
$AGIO Analyst Ratings
Wall Street analysts have issued reports on $AGIO in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 12/24/2025
- Citigroup issued a "Buy" rating on 11/26/2025
- Truist Securities issued a "Buy" rating on 11/24/2025
- Leerink Partners issued a "Outperform" rating on 11/20/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/20/2025
- Scotiabank issued a "Sector Outperform" rating on 07/28/2025
To track analyst ratings and price targets for $AGIO, check out Quiver Quantitative's $AGIO forecast page.
$AGIO Price Targets
Multiple analysts have issued price targets for $AGIO recently. We have seen 9 analysts offer price targets for $AGIO in the last 6 months, with a median target of $34.0.
Here are some recent targets:
- Greg Harrison from B of A Securities set a target price of $34.0 on 12/24/2025
- Samantha Semenkow from Citigroup set a target price of $38.0 on 11/26/2025
- Gregory Renza from Truist Securities set a target price of $32.0 on 11/24/2025
- Tessa Romero from JP Morgan set a target price of $20.0 on 11/21/2025
- Andrew Berens from Leerink Partners set a target price of $34.0 on 11/20/2025
- Salveen Richter from Goldman Sachs set a target price of $25.0 on 11/20/2025
- Emily Bodnar from HC Wainwright & Co. set a target price of $48.0 on 11/20/2025
You can track data on $AGIO on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
